To achieve simultaneous detection of multiple targets in a single test zone, multiplex rapid tests exploit the intrinsic color difference between distinct colloidal metal nanoparticle labels—like red gold and yellow silver—to create a visually interpretable, mixed-capture assay. By immobilizing a blend of capture antibodies specific to each analyte on the membrane and using separate detector antibodies tagged with optically distinct metal colloids, a single test line can produce a color pattern that corresponds to each target’s presence. This approach demands extremely high antibody specificity, rigorous control of conjugate geometry, and precision fluid dispensing to avoid cross-reactivity while maintaining clear signal resolution.
Core insight: Colour-differentiated metal sol labels (e.g., gold and silver nanoparticles) enable one-zone multiplexing by converting each target into a unique optical signal, but success depends entirely on antibody orthogonality and the colloidal stability of each conjugate. For developers, this means that the choice of raw materials and the inline mixing process are just as critical as the optical design.
The Principle of Colour-Differentiated Metal Nanoparticle Labels
The simplest way to multiplex on a lateral-flow strip is to let the colour of the signal tell you which analyte is present—right on the same test line. This technique works because noble metal nanoparticles scatter and absorb light very differently depending on their composition, size, and shape.
How Gold and Silver Colloids Enable One-Zone Multiplexing
Gold nanoparticles classically appear ruby‑red due to their localized surface plasmon resonance peak around 520 nm. Silver nanoparticles, depending on their diameter, can be tuned from yellow to brown or even green, with a plasmon peak shifted well below 500 nm. When both are used as detector labels conjugated to different target-specific antibodies, the human eye can distinguish the warm red‑pink signal of gold from the cooler yellow‑brown signal of silver on the same nitrocellulose membrane. A simple visual readout—or a low‑cost RGB camera—can then deconvolve the mixture. This one‑zone strategy reduces membrane real estate and allows multiple answers from a single sample flow.
The Role of Capture Antibody Mixtures
To make a single test line responsive to two or more targets simultaneously, the capture antibody cocktail must be carefully balanced. Each capture antibody is physically adsorbed or covalently attached to the membrane, but they sit alongside one another in the same narrow band. All capture antibodies in the mix must have comparable immobilisation kinetics and remain stable in the dispensing buffer; otherwise, one target gets underrepresented. This homogeneous‑zone approach relies on the detector conjugates flowing through and selectively “lighting up” only their matched capture partner. If the capture antibodies are not perfectly orthogonal, false colour mixing or weak signal can occur.
Ensuring Specificity and Signal Clarity
Moving from a single‑target test to a multiplexed strip with metal colloids introduces new failure modes. Every component must be optimized to suppress noise and crosstalk.
Hard Requirements for Antibody Pairs
Multiplexing with co‑immobilised capture reagents demands detection antibody pairs that show zero detectable cross‑reactivity against each other’s targets. Even a 1 % cross‑reaction can produce a faint silver signal where only gold should appear, undermining clinical interpretation. Antibodies must be screened in the exact matrix—same running buffer, same membrane type, same conjugate‑to‑capture ratio—because cross‑reactivity can be amplified by avidity effects when both capture and detector clones are present in close proximity. This screening is not optional; it is the foundation of the entire multiplex architecture.
Manufacturing Precision for Consistent Results
The visual separation between gold and silver labels depends on uniform particle size and consistent optical density. Variable conjugate batches produce line colours that shift from batch to batch, making visual interpretation unreliable. Dispensing the capture antibody mixture also demands high‑precision pumps that do not perturb the antibody ratio during long coating runs. Any drift in concentration across a reel alters the perceived colour balance, creating false negative or false positive zones. Optimized blocking and drying steps are equally important to prevent the colloidal particles from aggregating inside the conjugate pad, which would destroy colour purity.
Understanding the Trade‑offs
While colour‑coded metal colloid multiplexing is elegant, it comes with intrinsic limits that assay developers must weigh against their target product profile.
Limits of Visual Discrimination
Human colour perception can routinely distinguish red from yellow, but intermediate hues—like orange from a weak gold signal mixed with a strong silver signal—are easily misinterpreted. This forces a lower limit on the usable dynamic range and restricts the method to qualitative or semi‑quantitative yes/no calls unless a reader is employed. Moreover, only two, perhaps three, distinct metal nanoparticle colours can be reliably resolved by eye on a white membrane, capping the practical multiplexing depth.
Cross‑Reactivity Risks Multiply
Every added analyte increases the number of potential antibody‑antibody interactions. What works cleanly for two analytes can quickly become problematic when expanding to three or four, even with the same nanoparticle colours. Developers must consider whether moving to a spatial separation design—where each analyte has its own capture line and a single gold conjugate—offers a better risk‑to‑performance ratio for higher‑plex needs, even though that consumes more membrane length.
Making the Right Choice for Your Diagnostic Development
Consider your end‑user scenario and your tolerance for complexity before committing to a single‑zone metallo‑chromatic design. Use these goal‑oriented guidelines to stay on track.
- If your primary focus is a low‑cost, instrument‑free multiplex test for two or three analytes: Leverage gold‑silver colour differentiation with a single test‑line format. The simplicity of a single zone and visual readout will minimize strip cost and user training, provided you invest heavily in orthogonal antibody screening.
- If your primary focus is high‑sensitivity quantification: Deploy a reader. A simple CMOS camera can deconvolve overlapping plasmonic spectra and read out precise line intensities for each nanoparticle colour, turning the colorimetric multiplex into a fully quantitative tool.
- If your primary focus is low cross‑reactivity risk and simpler development: Adopt spatial multiplexing. Using separate capture lines with a single gold conjugate eliminates colour‑mixing ambiguity and reduces the need for perfectly orthogonal detection pairs, at the expense of slightly longer strips and larger sample volumes.
Capitalize on the natural colour signatures of metal nanoparticles to deliver multiplexed answers in a single drop—but always invest in the antibody and dispensing quality that makes colour mean clarity.
Summary Table:
| Label / Architecture | Optical Signal (LSPR Peak) | Primary Advantage | Main Limitation / Risk | Key Requirement |
|---|---|---|---|---|
| Gold Colloids (AuNPs) | Ruby Red (~520 nm) | High contrast, classic stability | Single target color alone | High colloidal stability & |
| precise conjugation | ||||
| Silver Colloids (AgNPs) | Yellow-Brown (<500 nm) | Distinct color shift from AuNPs | Batch-to-batch optical variance | Strict size uniformity & spectral control |
| One-Zone Multiplex | Mixed Red / Yellow Hues | Compact membrane, low cost | Limit to 2–3 visual targets | Perfect antibody orthogonality (0% crosstalk) |
| Spatial Multiplex | Distinct Red Lines per Target | Zero color-mixing risk | Consumes longer membrane real estate | Balanced flow kinetics across lines |
Developing next-generation multiplex lateral flow assays? CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to premium IVD raw materials, technical services, and consulting—covering every stage from concept to clinic. From highly orthogonal antibody pairs to color-stable nanoparticle conjugates, we help you overcome cross-reactivity and optimize your assay resolution. Contact CamelBio today to elevate your diagnostic development!